Australia markets closed

Oculis Holding AG (OCS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.70+0.08 (+0.83%)
At close: 04:00PM EST

Oculis Holding AG

Bahnhofstrasse 7
Zug 6300
41 58 810 0182

Full-time employees28

Key executives

NameTitlePayExercisedYear born
Dr. Riad Sherif M.B.A., M.D.CEO & DirectorN/AN/A1968
Ms. Sylvia CheungChief Financial OfficerN/AN/A1975
Mr. Weibo DingGlobal COO & GM of ChinaN/AN/A1971
Dr. Bastian DehmelChief Development Officer & Head of DevelopmentN/AN/A1971
Dr. Joanne Chang M.D., Ph.D.Head of Medical Affairs & Chief Medical OfficerN/AN/A1961
Mr. Páll Ragnar JóhannessonChief Strategy OfficerN/AN/A1981
Dr. Fang LiSenior Vice President of Regulatory AffairsN/AN/AN/A
Ms. Rebecca WeilChief Commercial OfficerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

Corporate governance

Oculis Holding AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.